Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

116
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
116
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

116
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
116
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

93
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
93
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

89
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
89
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

132
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
132
Peripheral Nervous System: Ganglia and Nerves01:24

Peripheral Nervous System: Ganglia and Nerves

3.5K
The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anhidrosis: An underappreciated factor in dermatologic diseases.

Journal of the American Academy of Dermatology·2026
Same author

Voice and Speech in Atypical Parkinsonian Disorders.

Movement disorders clinical practice·2026
Same author

To Exercise at High Intensity Heart Rate or Not to Exercise at High Intensity Heart Rate?

Movement disorders clinical practice·2026
Same author

Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body Dementia.

Annals of clinical and translational neurology·2025
Same author

A Case Report of Abdominal Myoclonus Following Anterior Cerebral Artery Stroke.

Tremor and other hyperkinetic movements (New York, N.Y.)·2025
Same author

Patient-Oriented Priorities for Pediatric Erythromelalgia: A Priority-Setting Process.

Children (Basel, Switzerland)·2025

Related Experiment Video

Updated: Nov 6, 2025

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.4K

A practical approach to peripheral autonomic neuropathies.

Guillaume Lamotte1, Paola Sandroni

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.

Current Opinion in Neurology
|May 11, 2021
PubMed
Summary

This review details evaluating and managing autonomic neuropathies. Effective treatment combines disease-modifying, symptomatic, and non-pharmacological approaches, with outcomes measured by biomarkers.

More Related Videos

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.0K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.7K

Related Experiment Videos

Last Updated: Nov 6, 2025

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.4K
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
08:56

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

3.0K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.7K

Area of Science:

  • Neurology
  • Autonomic Medicine

Background:

  • Autonomic neuropathies present complex, diverse clinical manifestations impacting multiple organ systems.
  • A thorough autonomic medical history is crucial for diagnosis and guiding further evaluation.
  • These disorders affect cardiovascular, gastrointestinal, urogenital, and sudomotor functions.

Purpose of the Study:

  • To provide a practical guide for the evaluation and management of patients with autonomic neuropathies.
  • To highlight the importance of a systematic approach in diagnosing and treating these complex conditions.

Main Methods:

  • Review of current literature and clinical practices in autonomic neuropathy.
  • Emphasis on the role of detailed patient history in clinical assessment.
  • Integration of laboratory and specialized autonomic testing.

Main Results:

  • Clinical evaluation and management strategies for autonomic neuropathies are presented.
  • Treatment involves a multimodal approach: disease-modifying therapies, symptomatic pharmacologic treatments, and nonpharmacological management.
  • Quantitative autonomic biomarkers can assess treatment response.

Conclusions:

  • Individualized treatment plans are essential, considering disease state, medication profiles, and cost.
  • Advances in genetic and pathological understanding are driving the development of novel disease-modifying therapies.
  • Personalized medicine approaches are key to optimizing patient outcomes in autonomic neuropathies.